Literature DB >> 17962811

Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms.

Vassiliki N Tzelepi1, Athanassios C Tsamandas, Helen D Vlotinou, Constantine E Vagianos, Chrisoula D Scopa.   

Abstract

Claudins and occludin are integral constituents of tight junctions and are deregulated in a variety of malignancies. Their role in thyroid carcinogenesis has not yet been elucidated. This study investigates the expression of occludin and claudin-1, -4 and -7 in thyroid neoplasms. Ninety-one thyroid neoplasms (15 follicular adenomas, 15 follicular carcinomas, 26 papillary carcinomas, 16 papillary microcarcinomas, 8 medullary carcinomas, 3 poorly differentiated carcinomas, 8 undifferentiated carcinomas) were immunostained with antibodies against occludin and claudin-1, -4 and -7. Occludin was mainly expressed in the form of intracytoplasmic vesicles, whereas all claudins tested exhibited membranous immunostaining. Thirteen out of 15 follicular adenomas, 10/15 follicular carcinomas, 24/26 papillary carcinomas, 15/16 papillary microcarcinomas, 1/8 medullary carcinomas, 2/3 poorly differentiated carcinomas and 2/8 undifferentiated carcinomas exhibited claudin-1 expression, whereas claudin-4 was expressed in 13/15, 12/15, 23/26, 13/16, 7/8, 2/3 and 2/8 of the tumors, respectively, and claudin-7 expression was found in 67, 33, 73, 69, 25, 0 and 13% of the cases, respectively. Occludin was expressed in 100% follicular adenomas, 80% follicular carcinomas, 96% papillary carcinomas, 50% papillary microcarcinomas, 50% medullary carcinomas, 33% poorly differentiated carcinomas and 88% undifferentiated carcinomas. Occludin expression was reduced in papillary microcarcinomas, medullary carcinomas and poorly differentiated carcinomas. All claudins exhibited reduced expression in undifferentiated carcinomas. Claudin-1 was additionally reduced in medullary carcinomas and claudin-7 in follicular, medullary and poorly differentiated carcinomas. A correlation between loss of claudin-1 expression and worse disease-free survival was noted on univariate analysis. Dedifferentiation of the thyroid carcinomas is accompanied by reduction in claudin-1, -4 and -7 expression. A differential expression of tight junction proteins in the different histologic types of thyroid gland is noted. Additionally, claudin-1 expression may be an important prognostic indicator of recurrence in thyroid carcinomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962811     DOI: 10.1038/modpathol.3800959

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  23 in total

1.  Expression pattern of claudins 1 and 3-an auxiliary tool in predicting behavior of mucoepidermoid carcinoma of salivary gland origin.

Authors:  Katri Aro; Luiz Eduardo Blumer Rosa; Ibrahim O Bello; Ylermi Soini; Antti A Mäkitie; Tuula Salo; Ilmo Leivo
Journal:  Virchows Arch       Date:  2010-12-24       Impact factor: 4.064

2.  Occludin localizes to centrosomes and modifies mitotic entry.

Authors:  E Aaron Runkle; Jeffrey M Sundstrom; Kristin B Runkle; Xuwen Liu; David A Antonetti
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

3.  Down regulated expression of Claudin-1 and Claudin-5 and up regulation of β-catenin: association with human glioma progression.

Authors:  Hanuma K Karnati; Manas Panigrahi; Noor A Shaik; Nigel H Greig; S Appala R Bagadi; Mohammad A Kamal; Nagaiah Kapalavayi
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

4.  The Value of HBME-1 and Claudin-1 Expression Profile in the Distinction of BRAF-Like and RAS-Like Phenotypes in Papillary Thyroid Carcinoma.

Authors:  Hasan Gucer; Pelin Bagci; Recep Bedir; Ibrahim Sehitoglu; Ozgur Mete
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

5.  Expression of claudin 1, 4 and 7 in thyroid neoplasms.

Authors:  Dinç Süren; Mustafa Yildirim; Alper Sayiner; Arsenal Sezgin Alikanoğlu; Irem Atalay; Umut Riza Gündüz; Vildan Kaya; Şeyda Gündüz; Mehmet Tahir Oruç; Cem Sezer
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

6.  Expression of claudin-1 and -7 in clear cell renal cell carcinoma and its clinical significance.

Authors:  Hong Il Shin; Byung Hoon Kim; Hyuk Soo Chang; Chun Il Kim; Hye Ra Jung; Choal Hee Park
Journal:  Korean J Urol       Date:  2011-05-24

7.  Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.

Authors:  Zsuzsanna Németh; Attila Marcell Szász; Péter Tátrai; Júlia Németh; Hajnalka Gyorffy; Aron Somorácz; Attila Szíjártó; Péter Kupcsulik; András Kiss; Zsuzsa Schaff
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

8.  High expression of claudin-1 protein in papillary thyroid tumor and its regional lymph node metastasis.

Authors:  Júlia Németh; Zsuzsanna Németh; Péter Tátrai; Ilona Péter; Aron Somorácz; Attila Marcell Szász; András Kiss; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2009-07-05       Impact factor: 3.201

9.  Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.

Authors:  Neetu Dahiya; Kevin G Becker; William H Wood; Yongqing Zhang; Patrice J Morin
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

10.  Apoptosis signal-regulating kinase 1 is associated with the effect of claudin-6 in breast cancer.

Authors:  Yaxiong Guo; Xiaoming Xu; Zhijing Liu; Ting Zhang; Xiaowei Zhang; Liping Wang; Min Wang; Yuanyuan Liu; Yan Lu; Yunpeng Liu; Chengshi Quan
Journal:  Diagn Pathol       Date:  2012-08-27       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.